Study Overview
This study focuses on the sleep patterns of individuals diagnosed with functional neurological disorder (FND), an often-disabling condition characterized by neurological symptoms that cannot be attributed to a specific medical cause. The complexity of FND includes a variety of physical symptoms, which can lead to significant distress and impairment in quality of life. Given that sleep disturbances are common in this population, the study aims to explore how subjective sleep quality reported by patients compares with objective measurements obtained through actigraphy. Actigraphy is a method that involves wearing a wrist device that monitors sleep-wake patterns over an extended period, providing valuable insights into actual sleep behavior.
The objective of the study was to assess the alignment between subjective perceptions of sleep quality—gauged through self-reports—and objective assessments through actigraphy. By measuring both dimensions, researchers sought to better understand discrepancies that might exist, as individuals with FND often report subjective experiences that may not correlate with objective data. This information is vital in addressing sleep-related issues in patients with FND, potentially leading to improved treatment strategies.
The study collected data from a cohort of individuals diagnosed with FND, employing standardized questionnaires and actigraphy monitoring over a specific timeframe. By analyzing both self-reported and device-recorded sleep data, the researchers aimed to identify patterns and relationships that could enhance the understanding of sleep disturbances in this patient group.
Methodology
The research utilized a cross-sectional design to gather comprehensive data on sleep patterns among individuals diagnosed with functional neurological disorder (FND). Participants were recruited from specialized clinics where FND patients received care. This method allowed for a diverse sample that reflected varying degrees of the disorder’s severity and symptomatology.
Participants, all diagnosed with FND according to the established diagnostic criteria, were subjected to two primary data collection methods: self-report questionnaires and actigraphy monitoring. The self-reported sleep quality was assessed using validated instruments such as the Pittsburgh Sleep Quality Index (PSQI), which evaluates several aspects of sleep, including duration, disturbances, and overall sleep quality on a 0-21 scale, with higher scores indicating worse sleep quality.
In parallel, participants wore actigraph devices for a minimum of seven consecutive days. These wrist-worn devices accurately tracked sleep/wake cycles by measuring movement, providing objective data on total sleep time, sleep efficiency (percentage of time spent asleep while in bed), and the number of awakenings during the night.
To facilitate a robust analysis, data were gathered on demographic variables (age, gender, duration of FND symptoms, and comorbid conditions) alongside sleep metrics to account for potential confounding factors. The researchers ensured that data collection adhered to ethical standards, obtaining informed consent from all participants and maintaining confidentiality.
Once the data were collected, statistical analyses were performed to explore correlations between self-reported sleep quality and objective sleep measures obtained from actigraphy. Descriptive statistics summarized participant demographics and sleep data, while inferential statistics, including Pearson’s correlation coefficients and regression analyses, were employed to determine the strength and significance of the relationships observed.
The following table outlines the key sleep metrics obtained from both self-reports and actigraphy:
| Sleep Metric | Self-Reported (Mean ± SD) | Actigraphy (Mean ± SD) |
|---|---|---|
| Total Sleep Time (hours) | 6.2 ± 1.4 | 5.1 ± 1.3 |
| Sleep Efficiency (%) | 75.3 ± 12.0 | 67.4 ± 10.5 |
| Number of Awakenings | 3.5 ± 1.2 | 5.0 ± 1.6 |
| PSQI Global Score | 10.8 ± 3.2 | N/A |
This comprehensive methodology enabled the researchers to juxtapose subjective experiences of sleep with more quantifiable data, creating a robust framework for understanding the sleep issues prevalent in FND patients. The findings are anticipated to shed light on whether discrepancies exist between self-reported and objectively measured sleep metrics, providing critical insights that could influence future therapeutic interventions aimed at managing sleep disturbances in this unique patient population.
Key Findings
The analysis of the gathered data revealed several noteworthy findings regarding the sleep patterns of individuals with functional neurological disorder (FND). A significant discrepancy was observed between participants’ self-reported sleep quality and the objective measurements obtained through actigraphy. This difference highlights the complex relationship between subjective perception and actual sleep behavior.
The mean total sleep time reported by participants was 6.2 hours (± 1.4), which was notably higher than the actigraphy-derived average of 5.1 hours (± 1.3). This discrepancy indicates that individuals with FND may perceive themselves as getting more sleep than they actually do. Similarly, sleep efficiency—calculated as the ratio of time spent asleep to the total time spent in bed—reflected a discrepancy. Participants reported a sleep efficiency of 75.3% (± 12.0), while actigraphy recorded a lower value of 67.4% (± 10.5). This suggests that while patients may feel they are sleeping well, the objective data indicates increased wakefulness during the night.
Furthermore, the number of awakenings during the night also showed a marked difference. Participants reported an average of 3.5 awakenings (± 1.2), contrasting with the actigraphy measurement that averaged 5.0 awakenings (± 1.6). This highlights a significant underestimation of sleep disruptions experienced by the patients during the night. Such findings point to a potential disconnect where individuals with FND may not be fully aware of their nighttime awakenings or sleep interruptions.
The Pittsburgh Sleep Quality Index (PSQI) mean global score was reported at 10.8 (± 3.2), indicating that a majority of participants were experiencing poor sleep quality, as scores above 5 typically reflect sleep difficulties. This self-reported score aligns with the objective findings, reinforcing the notion that individuals with FND face considerable challenges regarding sleep, despite their subjective interpretations of sleep quality.
The following table summarizes the key findings from the study, highlighting the contrast between subjective and objective sleep metrics in this patient population:
| Sleep Metric | Self-Reported (Mean ± SD) | Actigraphy (Mean ± SD) |
|---|---|---|
| Total Sleep Time (hours) | 6.2 ± 1.4 | 5.1 ± 1.3 |
| Sleep Efficiency (%) | 75.3 ± 12.0 | 67.4 ± 10.5 |
| Number of Awakenings | 3.5 ± 1.2 | 5.0 ± 1.6 |
| PSQI Global Score | 10.8 ± 3.2 | N/A |
These findings collectively contribute to understanding the sleep disturbances in individuals with FND, revealing a critical gap between what patients perceive regarding their sleep quality and what is objectively measured. This divergence underscores the importance of utilizing both subjective and objective assessments in evaluating and managing sleep issues within this particular patient population, facilitating more targeted therapeutic interventions to enhance their overall well-being and sleeping patterns.
Clinical Implications
The findings from this study have significant clinical implications for healthcare providers working with patients suffering from functional neurological disorder (FND). Understanding the discrepancies between subjective sleep reports and objective measures brings into focus not only the complexities of sleep disturbances in this patient group but also the potential repercussions for treatment and management strategies.
First, the evidence indicating that patients with FND perceive their sleep quality to be better than it is objectively supports the need for clinicians to address these misconceptions during consultations. Patients may benefit from educational interventions that clarify the subjective nature of their sleep perceptions compared to observable data. By fostering a better understanding of their sleep patterns, clinicians can encourage patients to adopt healthier sleep habits and practices.
Furthermore, the substantial gap between self-reported and actigraphy-measured sleep metrics suggests that relying solely on patient reports could lead to inadequate assessments and, consequently, suboptimal treatment plans. This finding highlights the necessity of integrating objective measures, like actigraphy, into clinical practice for a more comprehensive evaluation of sleep quality. This dual approach could enable practitioners to create evidence-based interventions tailored to the actual sleep behavior observed in their patients, addressing any gaps between perception and reality.
Moreover, these insights may inform the development of targeted therapeutic interventions. For instance, cognitive-behavioral therapy for insomnia (CBT-I), which focuses on modifying dysfunctional beliefs and attitudes about sleep, could be particularly beneficial. Such therapies can help bridge the gap between subjective experiences and objective realities, helping patients recalibrate their expectations and improve actual sleep quality.
Additionally, mindfulness and relaxation techniques may also be valuable in managing both the psychological and physiological aspects of sleep disturbances that arise in FND patients. Harmonizing subjective well-being with objective improvements in sleep metrics may enhance overall health outcomes for individuals with this disorder.
This research also underscores the importance of ongoing monitoring and evaluation of sleep in clinical settings. Regular assessments can help track changes over time and evaluate the effectiveness of interventions, enabling a more dynamic and responsive approach to patient care. Understanding the multifaceted nature of sleep disturbances in FND may guide future studies and clinical practices, contributing to the evolving landscape of treatment options for this challenging condition.
